Riskpilot← Back to searchSign inGet full accessORTOWEAR ApS
APSActiveCVR 31605822Mukkerten 21Wholesale of pharmaceutical and medical goods · NACE 4646Est. 20087 employees
Revenue 2024
DKK 4,5M
+23% vs 2023
EBITDA margin
29.6%
+71% vs 2023
Equity ratio
8.0%
Financial strength
Net profit 2024
DKK -11K
-112% vs 2023
| Revenue | DKK 4,5M | +23% |
| EBITDA | DKK 1,3M | +71% |
| Net profit | DKK -11K | -112% |
| Total assets | DKK 5,3M | +47% |
| Equity | DKK 425K | -3% |
| Employees | 7 | — |
Legal name
ORTOWEAR ApS
CVR number
31605822
Legal form
Anpartsselskab
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
1. juli 2008
Share capital
DKK 125.000
Employees
7 (FTE)
VAT registered
Yes
Audit selected
Yes
Last report
2024-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af en direktør alene.
Company purpose
Selskabets formål er udøve virksomhed i forbindelse med international handel og salg med fokus på skorelaterede produkter, produkter til ortopædiindustien samt netværksløsninger.
Address
Mukkerten 21
Phone
+4577344652
Email
cjr@mpac.biz
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 485 | 567 | 813 | 1.074 | 1.768 | 2.209 | 2.765 | 3.294 | 3.018 | 3.639 | 3.185 | 3.687 | 4.549 |
| Staff expenses | -411 | -372 | -573 | -874 | -874 | -1.762 | -2.470 | -2.761 | -2.247 | -2.617 | -2.751 | -2.900 | -3.201 |
| EBITDA | 47 | 169 | 230 | 223 | 604 | 446 | 295 | 532 | 771 | 1.022 | 434 | 788 | 1.348 |
| Depreciation & amort. | -0 | -0 | -0 | -18 | -17 | -105 | -146 | -81 | -58 | -71 | -86 | -239 | -451 |
| EBIT | 47 | 169 | 230 | 205 | 587 | 341 | 150 | 451 | 713 | 951 | 349 | 549 | 897 |
| Net financials | -33 | -21 | -4 | -1 | 37 | 7 | 22 | -13 | 8 | 115 | 9 | -429 | -736 |
| Profit before tax | 14 | 148 | 225 | 204 | 624 | 348 | 172 | 438 | 721 | 1.067 | 358 | 120 | 162 |
| Tax | 4 | 38 | 56 | 49 | 138 | 78 | 41 | 98 | 159 | 233 | 78 | 26 | 173 |
| Net profit | 10 | 110 | 170 | 155 | 486 | 270 | 130 | 340 | 562 | 833 | 280 | 94 | -11 |
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 259 | 354 | 747 | 1.034 | 1.885 | 1.978 | 2.518 | 3.133 | 2.543 | 2.739 | 2.658 | 3.632 | 5.349 |
| Equity | — | 195 | 365 | 420 | 806 | 576 | 706 | 1.047 | 709 | 962 | 742 | 436 | 425 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 86 | 193 | 0 | 0 | 0 | 0 |
| Short-term debt | 491 | 460 | 382 | 615 | 1.079 | 1.402 | 1.812 | 2.000 | 1.641 | 1.776 | 1.915 | 3.196 | 4.924 |
| Total debt | 491 | 460 | 382 | 615 | 1.079 | 1.402 | 1.812 | 2.086 | 1.834 | 1.776 | 1.915 | 3.196 | 4.924 |
EBITDA margin
29.6%
This company
15.8%
Market median
+87% vs market
20122024
Equity ratio
8.0%
This company
38.2%
Market median
-79% vs market
20122024
Return on equity
-2.6%
This company
18.4%
Market median
-114% vs market
20122024
Net profit margin
-0.2%
This company
8.1%
Market median
-102% vs market
20122024
Asset turnover
0.85×
This company
1.12×
Market median
+24% vs market
20122024
Debt / equity
11.57×
This company
0.62×
Market median
-1766% vs market
20122024
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via CVR / Virk · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via CVR / Virk · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via CVR / Virk · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via CVR / Virk · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via CVR / Virk · Period 2015-01-01 – 2015-12-31
- Annual report 2014Filed via CVR / Virk · Period 2014-01-01 – 2014-12-31
- Annual report 2013Filed via CVR / Virk · Period 2013-01-01 – 2013-12-31
- Annual report 2012Filed via CVR / Virk · Period 2012-01-01 – 2012-12-31
No data on file.
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Chairman | 2019 | — | — | |
| Deputy Chairman | 2019 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
Orto ApS | Company | 50.0% | 50.0% | 2023 |
RØNNEBY HOLDING ApS | Company | 33.3% | 33.3% | 2017 |
DANIDEA ApS | Company | 50.0% | 50.0% | 2017 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Orto ApS
ORTOWEAR ApS Board members of ORTOWEAR ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| René Engskov | Chairman | 0 companies |
| Carsten Jerring Rønneby | Deputy Chairman | 0 companies |